Extraction techniques are used to dissolve the metabolic products from the...
Extraction techniques are used to dissolve the metabolic products from the nutrient medium using suitable solvents. The liquid phase can then be analysed for its ingredients.

© Damian Gorczany

Revealing innovation potential of new antibiotics

Using proteomic profiling to accelerate drug development

The fight against bacterial infections, especially those caused by resistant pathogens, is in full swing with the search for new antibiotic agents. The aim is to identify substances that attack the pathogens in a truly novel way.

The team at the Center for Systems-Based Antibiotic Research (Cesar) at Ruhr-Universität Bochum (RUB) has described in two publications how assess if a new antibiotic has a new mechanism of action. They analysed the proteome, i.e. the totality of all proteins present in the bacterium, to learn how the cell reacts to stress. The team published their findings in the journal Antimicrobial Agents and Chemotherapy. In another paper in the journal Proteomics, the team evaluated the applicability of a method for determining the molecular target of antibiotics.

Photo
Dr. Christoph Senges with Julia Bandow, Head of the Center for Systems-Based Antibiotics Research

© RUB, Marquard

The researchers, including many RUB students, over many years have been studying changes in the proteome of the model organism Bacillus subtilis after exposure to various drugs. “The current study is a compilation of the responses to almost 100 substances,” explains Professor Julia Bandow, Chair of Applied Microbiology and Head of Cesar.

The bacterium’s response to antibiotic treatment mirrors the physiological stress, so to speak: for example, if the antibiotic causes a disruption of the fatty acid biosynthesis pathway, the enzymes in that pathway are upregulated. “Since it is quite well understood how Bacillus subtilis adapts to changing conditions and how the bacterium reacts to different stress factors, we often can use the proteome response to draw conclusions about which process in the cell is impaired by a new antibiotic,” Julia Bandow explains the comparison of proteomic responses approach, CoPR for short.

Photo
Dr. Sina Schäkermann is lead author of one of the two reports published on the proteome-based search for new antibiotically active substances.

© RUB, Marquard

This provides a basis for determining whether a promising new antibiotic substance has a similar effect to already known ones or whether it does indeed have a new mechanism of action. “We are always happy to see a new proteome response, because this indicates that the substance acts differently than the antibiotics previously tested,” explains the researcher. In that case, she says, the proteome is then analysed in great detail to build hypotheses on the cause of the response and thus the mechanism of action. As examples, the researchers examined more closely salvarsan, the first antibiotic ever used in humans, the antibiotic anti-rheumatic auranofin, a new atypical tetracycline, and the new class of trans-translation inhibitors.

For new antibiotics with innovative mechanisms of action, the next essential step is to elucidate the direct molecular target in the bacterial cell. To this end, the second study explored the applicability of a technique for target identification developed in Andrew Emili’s group (Boston University) to antibiotic research. It is based on chromatographic co-elution of active ingredient and target protein. The researchers incubated the proteins from bacterial cells with the antibiowtic allowing it to bind to its target. In the next step, the proteins were separated by chromatography. When the active ingredient tightly binds to the target protein, it travels with it during the separation process.

The research team then used mass spectrometry to search for the antibiotic. In addition to the target-bound antibiotic, excess free antibiotic can also be found. “When the active substance is subjected to the same chromatographic separation without proteins, it is possible to determine which of the fractions contain the free active substance. The other fractions are then those containing the target protein,” says Julia Bandow.

In their study, the Cesar team not only confirmed the site of action of a widely studied antibiotic, but also clarified that this technique can be used to detect many potential antibiotic targets. “This confirms the potential of this method for identifying new targets,” concludes Bandow.


Source: Ruhr-Universität Bochum (RUB)

20.10.2020

Read all latest stories

Related articles

Photo

Antibiotic resistance

Killer bugs put on the critical list

While new agents to fight virulent pathogens are in the pipeline, a new study pinpoints where a recent addition is already being applied in the clinic.

Photo

Knowing your enemy

New model to aid antibiotic resistance studies

Scientists in the UK have developed a new model that will help to advance the study of resistance to antibiotics.

Photo

Bacteria

Revolutionary antibiotics will save the world

An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.

Related products

i-Solutions Health – LabCentre

LIS, Middleware, POCT

i-Solutions Health – LabCentre

i-SOLUTIONS Health GmbH
Medat – Laboratory Information System

LIS, Middleware, POCT

Medat – Laboratory Information System

Medat Computer-Systeme GmbH
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH